• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项荟萃分析:精神障碍患者 COVID-19 的死亡率和严重程度。

A meta-analysis: The mortality and severity of COVID-19 among patients with mental disorders.

机构信息

Faculty of Medicine, the University of Jordan, Amman, 11942, Jordan..

Faculty of Medicine, the University of Jordan, Amman, 11942, Jordan.

出版信息

Psychiatry Res. 2021 May;299:113856. doi: 10.1016/j.psychres.2021.113856. Epub 2021 Mar 3.

DOI:10.1016/j.psychres.2021.113856
PMID:33740483
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7927594/
Abstract

Several observational studies investigated the relationship between pre-diagnosis with mental disorders and COVID-19 outcomes. Thus, we have decided to conduct this meta-analysis to explore this relationship. We complied to the PRISMA guidelines in conducting this meta-analysis. PubMed, ScienceDirect, Google Scholar and medRxiv were searched until the 15th of February, 2021. We used the Random effect model in Meta XL, version 5.3 to pool the included studies. Statistical heterogeneity was assessed using Cochran's Q heterogeneity test and I². This meta-analysis included 634,338 COVID-19 patients from 16 studies. Our findings revealed that pre-diagnosis with mental disorders increased the risk of COVID-19 mortality and severity. This increase in the risk of COVID-19 mortality and severity remained significant in the model that only included the studies that adjusted for confounding variables. Furthermore, higher mortality was noticed in the included studies among schizophrenia, schizotypal and delusional disorders patients compared to mood disorders patients. In this meta-analysis we provided two models which both reported a significant increase in the risk of  COVID-19 severity and mortality among patients with mental disorders, and with the upcoming COVID-19 vaccines, we recommend to give this category the priority in the vaccination campaigns along with medical health providers and elderly.

摘要

几项观察性研究调查了诊断前精神障碍与 COVID-19 结局之间的关系。因此,我们决定进行这项荟萃分析以探索这种关系。我们按照 PRISMA 指南进行这项荟萃分析。我们检索了 PubMed、ScienceDirect、Google Scholar 和 medRxiv,截至 2021 年 2 月 15 日。我们使用 Meta XL,版本 5.3 中的随机效应模型来合并纳入的研究。使用 Cochran's Q 异质性检验和 I²评估统计异质性。这项荟萃分析包括来自 16 项研究的 634338 名 COVID-19 患者。我们的研究结果表明,诊断前患有精神障碍会增加 COVID-19 死亡和严重程度的风险。在仅包括调整混杂变量的研究的模型中,这种 COVID-19 死亡率和严重程度增加的风险仍然显著。此外,与心境障碍患者相比,包括的研究中精神分裂症、类精神分裂症和妄想障碍患者的死亡率更高。在这项荟萃分析中,我们提供了两种模型,这两种模型都报告称,精神障碍患者 COVID-19 严重程度和死亡率的风险显著增加,随着即将推出的 COVID-19 疫苗,我们建议在疫苗接种活动中优先考虑这一类别,以及医疗保健提供者和老年人。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20bb/7927594/c56d0eea9e16/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20bb/7927594/3b0e23ef0145/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20bb/7927594/4e9e64e65826/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20bb/7927594/065dccdaa4b8/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20bb/7927594/d667393bae38/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20bb/7927594/8c6885b463f0/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20bb/7927594/f147b54474df/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20bb/7927594/c56d0eea9e16/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20bb/7927594/3b0e23ef0145/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20bb/7927594/4e9e64e65826/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20bb/7927594/065dccdaa4b8/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20bb/7927594/d667393bae38/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20bb/7927594/8c6885b463f0/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20bb/7927594/f147b54474df/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20bb/7927594/c56d0eea9e16/gr7_lrg.jpg

相似文献

1
A meta-analysis: The mortality and severity of COVID-19 among patients with mental disorders.一项荟萃分析:精神障碍患者 COVID-19 的死亡率和严重程度。
Psychiatry Res. 2021 May;299:113856. doi: 10.1016/j.psychres.2021.113856. Epub 2021 Mar 3.
2
Risk of SARS-CoV-2 infection, severe COVID-19 illness and COVID-19 mortality in people with pre-existing mental disorders: an umbrella review.患有精神障碍的人群中 SARS-CoV-2 感染、重症 COVID-19 疾病和 COVID-19 死亡率的风险:伞式综述。
BMC Psychiatry. 2023 Mar 20;23(1):181. doi: 10.1186/s12888-023-04641-y.
3
Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis.精神障碍与 COVID-19 相关死亡率、住院和重症监护病房入院风险:系统评价和荟萃分析。
Lancet Psychiatry. 2021 Sep;8(9):797-812. doi: 10.1016/S2215-0366(21)00232-7. Epub 2021 Jul 17.
4
Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic.与严重冠状病毒感染相关的精神和神经精神症状表现:一项系统综述和荟萃分析,并与新冠疫情进行比较
Lancet Psychiatry. 2020 Jul;7(7):611-627. doi: 10.1016/S2215-0366(20)30203-0. Epub 2020 May 18.
5
Association Between Mental Health Disorders and Mortality Among Patients With COVID-19 in 7 Countries: A Systematic Review and Meta-analysis.7 个国家的 COVID-19 患者心理健康障碍与死亡率之间的关联:系统评价和荟萃分析。
JAMA Psychiatry. 2021 Nov 1;78(11):1208-1217. doi: 10.1001/jamapsychiatry.2021.2274.
6
Proton Pump Inhibitors: Current Use and the Risk of Coronavirus Infectious Disease 2019 Development and its Related Mortality. Meta-analysis.质子泵抑制剂:当前的使用情况与 2019 年冠状病毒病发展及其相关死亡率的风险。荟萃分析。
Arch Med Res. 2021 Aug;52(6):656-659. doi: 10.1016/j.arcmed.2021.03.004. Epub 2021 Mar 26.
7
Association Between Mood Disorders and Risk of COVID-19 Infection, Hospitalization, and Death: A Systematic Review and Meta-analysis.心境障碍与 COVID-19 感染、住院和死亡风险的关联:系统评价和荟萃分析。
JAMA Psychiatry. 2021 Oct 1;78(10):1079-1091. doi: 10.1001/jamapsychiatry.2021.1818.
8
Deaths with COVID-19 and from all-causes following first-ever SARS-CoV-2 infection in individuals with preexisting mental disorders: A national cohort study from Czechia.首次感染 SARS-CoV-2 的伴有精神障碍的个体中 COVID-19 相关死亡和全因死亡:来自捷克的全国队列研究。
PLoS Med. 2024 Jul 15;21(7):e1004422. doi: 10.1371/journal.pmed.1004422. eCollection 2024 Jul.
9
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
10
The association of smoking status with SARS-CoV-2 infection, hospitalization and mortality from COVID-19: a living rapid evidence review with Bayesian meta-analyses (version 7).吸烟状况与SARS-CoV-2感染、COVID-19住院率及死亡率的关联:一项采用贝叶斯荟萃分析的实时快速证据综述(第7版)
Addiction. 2021 Jun;116(6):1319-1368. doi: 10.1111/add.15276. Epub 2020 Nov 17.

引用本文的文献

1
Trends in Diabetes Mellitus and Associated Mental Disorders-Related Mortality (1999-2023): A CDC WONDER Database Analysis.1999 - 2023年糖尿病及相关精神障碍相关死亡率趋势:美国疾病控制与预防中心WONDER数据库分析
Brain Behav. 2025 Aug;15(8):e70723. doi: 10.1002/brb3.70723.
2
Associations Between Psychosocial Influence, Positive Thinking, and Vaccine Attitudes in Patients with Schizophrenia During the COVID-19 Pandemic.COVID-19大流行期间精神分裂症患者的心理社会影响、积极思维与疫苗态度之间的关联
Psychol Res Behav Manag. 2025 Jun 10;18:1307-1318. doi: 10.2147/PRBM.S516814. eCollection 2025.
3
A Population-Based Cross-Sectional Investigation of COVID-19 Hospitalizations and Mortality Among Autistic People.

本文引用的文献

1
COVID-19, a worldwide public health emergency.COVID-19,一场全球性的公共卫生紧急事件。
Rev Clin Esp (Barc). 2021 Jan;221(1):55-61. doi: 10.1016/j.rceng.2020.03.001. Epub 2020 Apr 21.
2
Factors associated with COVID-19 related hospitalisation, critical care admission and mortality using linked primary and secondary care data.利用关联的初级和二级保健数据,分析与 COVID-19 相关住院、重症监护入院和死亡相关的因素。
Influenza Other Respir Viruses. 2021 Sep;15(5):577-588. doi: 10.1111/irv.12864. Epub 2021 May 4.
3
Pre-pandemic cognitive function and COVID-19 mortality: prospective cohort study.
一项基于人群的自闭症患者新冠病毒住院治疗及死亡情况的横断面调查。
J Autism Dev Disord. 2025 May 21. doi: 10.1007/s10803-025-06844-6.
4
Predictors of the Fear of COVID-19 in Individuals with Schizophrenia: a Prospective Study.精神分裂症患者对新冠病毒病恐惧的预测因素:一项前瞻性研究
Int J Med Sci. 2025 Mar 21;22(8):1916-1923. doi: 10.7150/ijms.106953. eCollection 2025.
5
Severe mental illness and infectious disease mortality: a systematic review and meta-analysis.严重精神疾病与传染病死亡率:一项系统综述和荟萃分析
EClinicalMedicine. 2024 Oct 9;77:102867. doi: 10.1016/j.eclinm.2024.102867. eCollection 2024 Nov.
6
Effectiveness of COVID-19 Vaccines in People with Severe Mental Illness: A Systematic Review and Meta-Analysis.新冠疫苗对重症精神疾病患者的有效性:一项系统评价与荟萃分析
Vaccines (Basel). 2024 Sep 18;12(9):1064. doi: 10.3390/vaccines12091064.
7
Increased antipsychotic drug concentration in hospitalized patients with mental disorders following COVID-19 infection: a call for attention.新冠病毒感染后精神障碍住院患者抗精神病药物浓度升高:需引起关注
Front Psychiatry. 2024 Jul 15;15:1421370. doi: 10.3389/fpsyt.2024.1421370. eCollection 2024.
8
Molecular overlaps of neurological manifestations of COVID-19 and schizophrenia from a proteomic perspective.从蛋白质组学角度看新冠病毒病与精神分裂症神经学表现的分子重叠
Eur Arch Psychiatry Clin Neurosci. 2025 Feb;275(1):109-122. doi: 10.1007/s00406-024-01842-8. Epub 2024 Jul 19.
9
Anti-spike antibody responses to SARS-CoV-2 mRNA vaccines in people with schizophrenia and schizoaffective disorder.精神分裂症和分裂情感性障碍患者对SARS-CoV-2 mRNA疫苗的抗刺突抗体反应。
Brain Behav Immun Health. 2024 Jun 3;38:100802. doi: 10.1016/j.bbih.2024.100802. eCollection 2024 Jul.
10
Is children's mental health an important function of newly national organization for health crisis management in Japan?儿童心理健康是否是日本新成立的国家健康危机管理组织的一项重要职能?
PCN Rep. 2024 Feb 13;3(1):e175. doi: 10.1002/pcn5.175. eCollection 2024 Mar.
大流行前的认知功能与 COVID-19 死亡率:前瞻性队列研究。
Eur J Epidemiol. 2021 May;36(5):559-564. doi: 10.1007/s10654-021-00743-7. Epub 2021 Apr 24.
4
Age and frailty are independently associated with increased COVID-19 mortality and increased care needs in survivors: results of an international multi-centre study.年龄和虚弱与 COVID-19 死亡率增加和幸存者护理需求增加独立相关:一项国际多中心研究的结果。
Age Ageing. 2021 May 5;50(3):617-630. doi: 10.1093/ageing/afab026.
5
Pre-pandemic psychiatric disorders and risk of COVID-19: a UK Biobank cohort analysis.大流行前的精神障碍与 COVID-19 风险:英国生物银行队列研究。
Lancet Healthy Longev. 2020 Nov;1(2):e69-e79. doi: 10.1016/S2666-7568(20)30013-1. Epub 2020 Oct 26.
6
Association of Psychiatric Disorders With Mortality Among Patients With COVID-19.精神障碍与 COVID-19 患者死亡率的关联。
JAMA Psychiatry. 2021 Apr 1;78(4):380-386. doi: 10.1001/jamapsychiatry.2020.4442.
7
Association of mental disorders with SARS-CoV-2 infection and severe health outcomes: nationwide cohort study.精神障碍与 SARS-CoV-2 感染及严重健康结局的关联:全国队列研究。
Br J Psychiatry. 2021 Jun;218(6):344-351. doi: 10.1192/bjp.2020.251.
8
Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA.新冠病毒与精神障碍之间的双向关联:美国 62354 例新冠病毒病例的回顾性队列研究。
Lancet Psychiatry. 2021 Feb;8(2):130-140. doi: 10.1016/S2215-0366(20)30462-4. Epub 2020 Nov 9.
9
Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial.氟伏沙明对比安慰剂在伴有症状的 COVID-19 门诊患者中的临床恶化:一项随机临床试验。
JAMA. 2020 Dec 8;324(22):2292-2300. doi: 10.1001/jama.2020.22760.
10
Machine learning prediction for mortality of patients diagnosed with COVID-19: a nationwide Korean cohort study.基于全国韩国队列研究的 COVID-19 患者死亡率的机器学习预测。
Sci Rep. 2020 Oct 30;10(1):18716. doi: 10.1038/s41598-020-75767-2.